4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-007814
CHIEF OPERATING OFFICER sold 12,409 shares at $21.06 ($261,334)
- CHIEF OPERATING OFFICER acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-03-10 | Option exercise 10b5-1 | +7,000 | $3.80 | $26,600 | 88,975 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-03-10 | Sale 10b5-1 | −12,409 | $21.06 | $261,334 | 76,566 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-03-10 | Option exercise · Share Option 10b5-1 | −7,000 | 14,049 | D | ||
| Open-market sales · 12,409 sh · avg $21.06 · $261,334 | |||||||
Loading xslF345X05/form4-03122025_080305.xml…